GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $127,000 | -20.6% | 1,300 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $160,000 | +40.4% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $114,000 | -16.2% | 1,300 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $136,000 | -9.3% | 1,300 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $150,000 | +57.9% | 1,300 | +136.4% | 0.01% | +50.0% |
| Q2 2019 | $95,000 | +21.8% | 550 | -21.4% | 0.00% | +100.0% |
| Q4 2016 | $78,000 | -16.1% | 700 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $93,000 | +45.3% | 700 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $64,000 | +25.5% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $51,000 | +4.1% | 700 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $49,000 | -23.4% | 700 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $64,000 | -25.6% | 700 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $86,000 | +34.4% | 700 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $64,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |